azoxymethane has been researched along with sulfasalazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohno, H; Miyamoto, S; Suzuki, R; Tanaka, T; Wakabayashi, K; Yasui, Y | 1 |
| Amakawa, M; Handa, T; Konishi, K; Matsumura, Y; Miyake, Y; Murata, T; Takeuchi, K; Tanaka, T; Watanabe, Y | 1 |
| Chen, S; Jing, X; Li, M; Liu, H; Liu, Y; Sun, B; Sun, T; Tian, Y; Wang, H; Yang, C; Zhang, Q; Zhao, J; Zhao, Y; Zong, S | 1 |
3 other study(ies) available for azoxymethane and sulfasalazine
| Article | Year |
|---|---|
Ursodeoxycholic acid versus sulfasalazine in colitis-related colon carcinogenesis in mice.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Colitis; Colonic Neoplasms; Cyclooxygenase 2; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; RNA, Messenger; Sulfasalazine; Ursodeoxycholic Acid | 2007 |
KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration.
Topics: Administration, Oral; Animals; Azoxymethane; Benzoates; Biological Availability; Cells, Cultured; Colitis, Ulcerative; Colonic Neoplasms; Cyclopropanes; Dextran Sulfate; Epoprostenol; Female; Healthy Volunteers; Humans; Intestinal Mucosa; Mice; Receptors, Prostaglandin E, EP4 Subtype; Sulfasalazine; Tumor Necrosis Factor-alpha | 2015 |
Therapeutic effects of lentinan on inflammatory bowel disease and colitis-associated cancer.
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Azoxymethane; Carcinoembryonic Antigen; CD30 Ligand; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Disease Models, Animal; Female; Gastrointestinal Microbiome; Gene Expression Regulation, Neoplastic; Hyperplasia; Interleukin-13; Keratin-18; Keratin-8; Lentinan; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Signal Transduction; Sulfasalazine; Toll-Like Receptor 4; Tumor Suppressor Protein p53 | 2019 |